Skip to content
10-Q

Quarterly Report

Chinook Therapeutics, Inc.

0001564590-22-037390

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 4, 2022 63.94M sh
Shares Diluted Q3 2022 · Sep 30, 2022 67.78M sh
Shares Diluted Q3 2022 · Sep 30, 2022 62.74M sh
Shares Diluted Q3 2022 · Sep 30, 2021 44.66M sh
Shares Diluted Q3 2022 · Sep 30, 2021 43.56M sh
Capex Q3 2022 · Sep 30, 2022 $970K
Capex Q3 2022 · Sep 30, 2021 $1.5M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$80.65M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$80.24M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $126.07M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $181.72M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $108.52M
Stockholders Equity Q3 2022 · Sep 30, 2022 $474.64M
Stockholders Equity Q3 2022 · Jun 30, 2022 $507.13M
Stockholders Equity Q3 2022 · Mar 31, 2022 $426.8M
Stockholders Equity Q3 2022 · Dec 31, 2021 $453.64M
Stockholders Equity Q3 2022 · Sep 30, 2021 $269.78M
Stockholders Equity Q3 2022 · Jun 30, 2021 $296.73M
Stockholders Equity Q3 2022 · Mar 31, 2021 $300.52M
Stockholders Equity Q3 2022 · Dec 31, 2020 $334.62M
Current Liabilities Q3 2022 · Sep 30, 2022 $44.74M
Current Liabilities Q3 2022 · Dec 31, 2021 $40.09M
Total Liabilities Q3 2022 · Sep 30, 2022 $115.7M
Total Liabilities Q3 2022 · Dec 31, 2021 $110.16M
Current Assets Q3 2022 · Sep 30, 2022 $381.67M
Current Assets Q3 2022 · Dec 31, 2021 $300.64M
Total Assets Q3 2022 · Sep 30, 2022 $590.34M
Total Assets Q3 2022 · Dec 31, 2021 $563.8M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.83
Eps Diluted Q3 2022 · Sep 30, 2022 −$2.00
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.69
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.54
Eps Basic Q3 2022 · Sep 30, 2022 −$0.83
Eps Basic Q3 2022 · Sep 30, 2022 −$2.00
Eps Basic Q3 2022 · Sep 30, 2021 −$0.69
Eps Basic Q3 2022 · Sep 30, 2021 −$2.54
Sga Expense Q3 2022 · Sep 30, 2022 $10.02M
Sga Expense Q3 2022 · Sep 30, 2022 $26.53M
Sga Expense Q3 2022 · Sep 30, 2021 $6.85M
Sga Expense Q3 2022 · Sep 30, 2021 $24.16M
Rd Expense Q3 2022 · Sep 30, 2022 $41.98M
Rd Expense Q3 2022 · Sep 30, 2022 $98.26M
Rd Expense Q3 2022 · Sep 30, 2021 $23.57M
Rd Expense Q3 2022 · Sep 30, 2021 $72.06M
Net Income Q3 2022 · Sep 30, 2022 −$55.98M
Net Income Q3 2022 · Sep 30, 2022 −$125.31M
Net Income Q3 2022 · Jun 30, 2022 −$37.65M
Net Income Q3 2022 · Mar 31, 2022 −$31.68M
Net Income Q3 2022 · Sep 30, 2021 −$30.7M
Net Income Q3 2022 · Sep 30, 2021 −$110.48M
Net Income Q3 2022 · Jun 30, 2021 −$42.57M
Net Income Q3 2022 · Mar 31, 2021 −$37.22M
Operating Income Q3 2022 · Sep 30, 2022 −$57.68M
Operating Income Q3 2022 · Sep 30, 2022 −$125.18M
Operating Income Q3 2022 · Sep 30, 2021 −$31.01M
Operating Income Q3 2022 · Sep 30, 2021 −$111.43M
Revenue Q3 2022 · Sep 30, 2022 $2.5M
Revenue Q3 2022 · Sep 30, 2022 $5.62M
Revenue Q3 2022 · Sep 30, 2021 $4K
Revenue Q3 2022 · Sep 30, 2021 $389K